Seattle, WA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Telephone-Based Cognitive Behavioral Therapy Significantly Improves Menopause Symptoms


Chatting on the phone with a “sleep coach” and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published in JAMA Internal Medicine. The...
19-May-2016 2:05 PM EDT Add to Favorites

Fred Hutch Hires Steve Stadum as Executive Vice President and Chief Operating Officer


Fred Hutchinson Cancer Research Center today announced the hiring of Steve Stadum as executive vice president and chief operating officer. Stadum, currently the COO of Oregon Health & Science University’s Knight Cancer Institute, in July will...
29-Apr-2016 3:05 PM EDT Add to Favorites

Study: 93 Percent of Advanced Leukemia Patients in Remission After Immunotherapy


Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells (disease-fighting immune cells) were genetically engineered to fight their cancers....
27-Apr-2016 4:05 PM EDT Add to Favorites

Dr. Philip Greenberg, Cancer Immunology Expert at Fred Hutch, to Present at AACR on Targeting Cancer with Engineered T Cells


Dr. Philip Greenberg, head of immunology and a member of the Clinical Research Division at Seattle’s Fred Hutchinson Cancer Research Center and a leader in cancer immunology, will describe how he and colleagues are genetically engineering T cells...
15-Apr-2016 3:05 PM EDT Add to Favorites

Fred Hutch President and Director Gary Gilliland Elected to American Academy of Arts and Sciences


Dr. Gary Gilliland, president and director of Fred Hutchinson Cancer Research Center, has been elected to membership in the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies and independent...
20-Apr-2016 4:30 AM EDT Add to Favorites

Merkel cell carcinoma patients who received pembrolizumab often had durable responses


In a phase 2 clinical trial of the immunotherapy drug pembrolizumab as a first-line systemic therapy for advanced Merkel cell carcinoma, or MCC – a rare, aggressive type of skin cancer – the clinical response rate was similar to that typically...
15-Apr-2016 5:05 PM EDT Add to Favorites

Precision Prevention of Colorectal Cancer


Precision medicine’s public face is that of disease — and better treatments for that disease through targeted therapies. But precision medicine has an unsung partner that could affect the lives of many more people: Precision prevention — a...
15-Apr-2016 6:05 PM EDT Add to Favorites

Women’s Health Initiative receives AACR Team Science Award

The Women’s Health Initiative, a nationwide, federally funded research program coordinated by Fred Hutchinson Cancer Research Center in Seattle, has received the 10th annual Team Science Award from the American Association for Cancer Research....
15-Apr-2016 5:05 PM EDT Add to Favorites

Our YouTube Videos